Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT03886155 · ClinicalTrials.gov registry record
Cardiac Amyloidosis Screening at Trigger Finger Release
A clinical trial, sponsored by The Cleveland Clinic.
- Completed
- Registry status
- 107
- Enrollment target
NCT03886155 is a clinical trial that has completed, run by The Cleveland Clinic. The registered enrollment target is 107 participants.
The verdict
NCT03886155 has completed, sponsored by The Cleveland Clinic.
- COMPLETED
- Registry status
- 107 participants
- Enrollment target
Study Summary
The investigators will prospectively evaluate for the presence of amyloid deposits in soft tissue samples obtained from patients undergoing trigger finger release surgery. Patients who have tissue that stains positive for amyloid will be referred to an amyloidosis specialist.
Interventions
- PROCEDURE Biopsy
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 107 participants |
| Start Date | 2019-05-01 |
| Est. Completion | 2021-12-02 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT03886155
The ClinicalTrials.gov registry entry for NCT03886155 describes a study currently listed as completed, categorized as an unspecified phase. The registered enrollment target is 107 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is The Cleveland Clinic, which has 688 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 1 intervention - of which Biopsy is the first listed.
NCT03886155 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT03886155 about?
NCT03886155 is a clinical study titled "Cardiac Amyloidosis Screening at Trigger Finger Release". The investigators will prospectively evaluate for the presence of amyloid deposits in soft tissue samples obtained from patients undergoing trigger finger release surgery. Patients who have tissue that stains positive for amyloid will be referred to an amyloidosis specialist.
What is the current status of trial NCT03886155?
This trial is currently completed. The enrollment target is 107 participants. The study started on 2019-05-01. Estimated completion is 2021-12-02.
What interventions are being tested in trial NCT03886155?
The interventions under investigation include: Biopsy (PROCEDURE).
Who is sponsoring clinical trial NCT03886155?
This trial is sponsored by The Cleveland Clinic, which has 688 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.